These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11098130)

  • 41. The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase).
    Vijayaraghavan J; Scicli AG; Carretero OA; Slaughter C; Moomaw C; Hersh LB
    J Biol Chem; 1990 Aug; 265(24):14150-5. PubMed ID: 2201681
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Processing and metabolism of peptide-YY: pivotal roles of dipeptidylpeptidase-IV, aminopeptidase-P, and endopeptidase-24.11.
    Medeiros MD; Turner AJ
    Endocrinology; 1994 May; 134(5):2088-94. PubMed ID: 7908871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolism of amyloid-beta peptide and Alzheimer's disease.
    Iwata N; Higuchi M; Saido TC
    Pharmacol Ther; 2005 Nov; 108(2):129-48. PubMed ID: 16112736
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Gene therapy for Alzheimer' s disease].
    Iwata N; Ozawa K; Saido TC
    Nihon Rinsho; 2005 Mar; 63(3):394-400. PubMed ID: 15773336
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11.
    Kenny AJ; Bourne A; Ingram J
    Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):83-8. PubMed ID: 8097089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hydrolysis of rat melanin-concentrating hormone by endopeptidase 24.11 (neutral endopeptidase).
    Checler F; Dauch P; Barelli H; Nahon JL; Vincent JP
    Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):217-21. PubMed ID: 1520271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
    Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS
    Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Messenger RNA-based therapeutics for brain diseases: An animal study for augmenting clearance of beta-amyloid by intracerebral administration of neprilysin mRNA loaded in polyplex nanomicelles.
    Lin CY; Perche F; Ikegami M; Uchida S; Kataoka K; Itaka K
    J Control Release; 2016 Aug; 235():268-275. PubMed ID: 27282413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of neprilysin by thiorphan (i.c.v.) causes an accumulation of amyloid beta and impairment of learning and memory.
    Mouri A; Zou LB; Iwata N; Saido TC; Wang D; Wang MW; Noda Y; Nabeshima T
    Behav Brain Res; 2006 Mar; 168(1):83-91. PubMed ID: 16360221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and characterization of a neutral endopeptidase activity in Aplysia californica.
    Bawab W; Aloyz RS; Crine P; Roques BP; DesGroseillers L
    Biochem J; 1993 Dec; 296 ( Pt 2)(Pt 2):459-65. PubMed ID: 8257438
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: possible physiological significance.
    Skolovsky M; Galron R; Kloog Y; Bdolah A; Indig FE; Blumberg S; Fleminger G
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4702-6. PubMed ID: 2191299
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ketamine reduces amyloid β-protein degradation by suppressing neprilysin expression in primary cultured astrocytes.
    Yamamoto N; Arima H; Naruse K; Kasahara R; Taniura H; Hirate H; Sugiura T; Suzuki K; Sobue K
    Neurosci Lett; 2013 Jun; 545():54-8. PubMed ID: 23624023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
    Asai M; Kawakubo T; Mori R; Iwata N
    Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protective effect of recombinant soluble neprilysin against β-amyloid induced neurotoxicity.
    Oh JH; Choi S; Shin J; Park JS
    Biochem Biophys Res Commun; 2016 Sep; 477(4):614-619. PubMed ID: 27395340
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new brain metalloendopeptidase which degrades the Alzheimer beta-amyloid 1-40 peptide producing soluble fragments without neurotoxic effects.
    Carvalho KM; França MS; Camarão GC; Ruchon AF
    Braz J Med Biol Res; 1997 Oct; 30(10):1153-6. PubMed ID: 9496430
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Degradation of lysylbradykinin by endopeptidase 24.11 and endopeptidase 24.15.
    Rosenbaum C; Cardozo C; Lesser M
    Peptides; 1995; 16(3):523-5. PubMed ID: 7651908
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neprilysin 2: a novel messenger peptide-inactivating metalloprotease.
    Ouimet T
    Protein Pept Lett; 2004 Oct; 11(5):479-89. PubMed ID: 15544569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Charge polarity reversal inverses the specificity of neutral endopeptidase-24.11.
    Beaumont A; Barbe B; Le Moual H; Boileau G; Crine P; Fournié-Zaluski MC; Roques BP
    J Biol Chem; 1992 Feb; 267(4):2138-41. PubMed ID: 1733922
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endopeptidase-24.11: putative substrates and possible roles.
    Kenny J
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):663-8. PubMed ID: 8224486
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.